There are currently patents in place that prevent any generic Forfivo XL products from being manufactured in the United States. When the patent expires in June 2027, a manufacturer may decide to make a generic version of the drug. However, circumstances could come up to delay the production of generic Forfivo XL, such as lawsuits or other patents for new uses of the medication.
Can I Buy Generic Forfivo XL?
Forfivo™ XL (bupropion XL) is a prescription medication approved for the treatment of depression. It is an extended-release version of bupropion that is taken once a day. It contains the highest strength of bupropion available in a single tablet: 450 mg.
Forfivo XL is made by Pillar5 Pharma, Inc., for IntelGenx Corp. It is currently protected by patents that prevent any generic versions from being sold in the United States.
When Will a Generic Version Be Available?
The first patent for Forfivo XL is set to expire in June 2027. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Forfivo XL uses. Once the drug goes off-patent, there may be several companies that manufacture a generic Forfivo XL drug.
Is Bupropion a Generic Forfivo XL?
No -- bupropion is the active ingredient in Forfivo XL (as well as numerous other medications), but it is not a generic version of it. There are generic versions of some other brand-name bupropion products (Wellbutrin®, Wellbutrin SR®, Wellbutrin XL®, and Zyban®), but these medications are not equivalent to Forfivo XL.
If your insurance company does not cover Forfivo XL, there is a good chance they will cover a generic version of one of the other bupropion products. Check with your healthcare provider and your insurance company about using one of these other products.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed December 15, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click